About this trial

The effects of single dose injection of platelet rich plasma or conditioned serum in the knee joint in patients with knee osteoarthritis will be compared

Eligibility criteria

Qualifiers

Diagnosis of knee osteoarthritis according to ACR criteria at least 6 months ago.

Being between grade 1-2 according to the Kellgren-Lawrence radiological classification.

Not having had PRP injection in the last year.

Knee pain ≥ 5 according to the visual pain scale.

Disqualifiers

Those with significant neurological or cardiovascular disorders.

Those with active thrombovascular disease.

Those with joint or skin infections.

Those who have recently had an infectious disease.

Trial design

Treatments tested in this trial

  • Autologous Platelet-Rich Plasma (PRP)
  • Conditioned serum (CS)

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Pamukkale University

Lead sponsor